CVS Health Says It Has Reached Settlement Agreement With FTC On Insulin Pricing, Final Terms Still Pending, To Be Confirmed Once Settlement Is Finalized In Coming Weeks

CVS Health has announced that it has reached a settlement agreement with the Federal Trade Commission (FTC) regarding insulin pricing. The final terms of the settlement are still pending and will be confirmed in the coming weeks. This development may have implications for CVS's operations and pricing strategies in the pharmaceutical sector.